Compare Organon & Co. Common Stock (OGN) vs TJX Companies Inc (TJX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs TJX Companies Inc — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while TJX Companies Inc trades at $142.97 (market cap $155.64B). The key difference: TJX Companies Inc is far larger — about 43× Organon & Co. Common Stock's market cap, and TJX Companies Inc pays the higher dividend (1.36%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and TJX Companies Inc for 97 Days on average.
| OGN | TJX | |
|---|---|---|
Market Cap | $3.62B | $155.64B |
Volume | 2,892,999 | 7,499,607 |
Sector | Health | Consumer Cyclical |
52-Week High | $13.81 | $168.41 |
52-Week Low | $5.70 | $122.84 |
Typical Hold Time | 0 Days | 97 Days |
Enterprise Value | $11.04B | $163.95B |
Dividend Yield | 0.58% | 1.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
TJX trades at $141.49, down 0.3% on the day, with a bullish technical outlook supported by moving averages and strong fundamentals. The company reported revenue of $56.36 billion in 2025, with net income of $4.86 billion and a net margin of 8.63%. Recent earnings beats and a consensus analyst price target of $174.15 suggest potential upside, while robust cash flow and a high ROE of 62.17% highlight operational strength.
The stock presents a favorable risk-reward profile with Wall Street overwhelmingly bullish (85% buy ratings), though elevated valuation multiples and overbought RSI readings warrant caution. Key risks include competitive pressures in off-price retail and macroeconomic sensitivity, but TJX's consistent execution and growth trajectory support a positive outlook for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →
